Solve M.E. Announces Emily Taylor as New President and CEO and Publication of New White Paper Calling for NIH to Restructure Funding for ME/CFS, Long Covid, and other IACCIs
Solve M.E. is pleased to announce that Emily Taylor, Vice President of Advocacy and Engagement, has been appointed as President and CEO. Emily has been a key member of Solve’s […]
Solve Releases New White Paper: A Home for Infection-Associated Chronic Conditions and Illnesses (IACCIs) at NIH
Complementing our Advocacy Week 2024 efforts, Solve has co-authored a new white paper, “A Home for Infection-Associated Chronic Conditions and Illnesses (IACCIs) at NIH.” Co-written by Solve President and CEO […]
Meet Our Partners for Advocacy Week 2024
Solve is proud to announce our partners for Advocacy Week 2024: #MEAction Black COVID Survivors Alliance Covid-19 Longhauler Advocacy Project Pandemic Patients Patient-Led Research Collaborative Solve M.E. Advocacy Week 2024 […]
New Study Using Solve Real-World Data (RWD) Examines Joint Hypermobility in People with ME/CFS
A new study published in the Autonomic Disorders section of Frontiers in Neurology uses data collected by Solve to identify a possible ME/CFS disease subgroup. “Do People with ME/CFS and […]
Solve VP of Advocacy Emily Taylor talks to STAT About the Push For a New Coordinating Mechanism at NIH for Infection-Associated Chronic Conditions
On March 15, Long Covid Awareness Day, Solve’s VP of Advocacy and Engagement Emily Taylor was quoted by STAT in its coverage of the push for a new office at […]
March 15 is International Long Covid Awareness Day
March 15 is International Long Covid Awareness Day. The United States Census Bureau Household Pulse Survey indicates that about 1 in 4 people — approximately 27,831,176 Americans — who […]
Susannah Fox Will be the Keynote Speaker for Solve’s 2024 EmPOWER M.E. Event
As part of Advocacy Week 2024, our EmPOWER M.E. roundtable on April 19 at 9 am PT / 12 pm ET will feature panels of patient advocates, professionals, and scientists […]
Solve Announces Congressional Asks for Advocacy Week 2024
Advocacy Week is a nationwide advocacy effort to connect people with ME/CFS, Long Covid, POTS and other dysautonomias, Chronic Lyme, and other infection-associated chronic conditions and illnesses; scientists; clinicians and […]
Solve Responds to Findings From the NIH Intramural ME/CFS Clinical Study Published in “Nature”
Findings from the National Institutes of Health (NIH) intramural ME/CFS clinical study were published in Nature Communications last week to mixed reception by the patient advocate community. Co-written by 75 […]
Solve Submits Comments on NIH-Wide Strategic Plan for Autoimmune Disease Research
The Office of Autoimmune Disease Research within the Office of Research on Women’s Health (OADR-ORWH) recently released the Request for Information (RFI): Inviting Input on an NIH-Wide Strategic Plan for […]
Solve at the NASEM Workshop: ME/CFS, Advocacy and Patient-Driven Data Platforms
The National Academies Forum on Microbial Threats and Forum on Neuroscience and Nervous System Disorders (NASEM) hosted a hybrid public workshop in June 2023 to explore opportunities to advance research […]
Ramsay Grant Researcher Rob Wüst in National Geographic, The NY Post
Ramsay Research Grant winner Rob C. I. Wüst (Ramsay Class of 2022) was in the news discussing his recently published results from a Solve-funded study on post-exertional malaise (PEM) that […]
